Thomas R. Cannell
2022 - Eleven Biotherapeutics
In 2022, Thomas R. Cannell earned a total compensation of $1.4M as Former President and Chief Executive Officer at Eleven Biotherapeutics, a 72% decrease compared to previous year.
Compensation breakdown
| Salary | $576,563 |
|---|---|
| Stock Awards | $813,719 |
| Other | $4,000 |
| Total | $1,394,282 |
Cannell received $813.7K in stock awards, accounting for 58% of the total pay in 2022.
Cannell also received $576.6K in salary and $4K in other compensation.
Rankings
In 2022, Thomas R. Cannell's compensation ranked 2,389th out of 5,760 executives tracked by ExecPay. In other words, Cannell earned more than 58.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,389 out of 5,760 | 59th |
Division Manufacturing | 1,312 out of 3,136 | 58th |
Major group Chemicals And Allied Products | 585 out of 1,422 | 59th |
Industry group Drugs | 540 out of 1,323 | 59th |
Industry Pharmaceutical Preparations | 391 out of 969 | 60th |
Source: SEC filing on April 28, 2023.
Cannell's colleagues
We found two more compensation records of executives who worked with Thomas R. Cannell at Eleven Biotherapeutics in 2022.
News
Eleven Biotherapeutics CEO Steven Kelly receives $3.5M in 2023
April 29, 2024
Eleven Biotherapeutics CEO Thomas Cannell's 2022 pay falls 72% to $1.4M
April 28, 2023
Eleven Biotherapeutics CEO Thomas Cannell's 2021 pay jumps 189% to $4.9M
April 28, 2022
Eleven Biotherapeutics CEO Thomas Cannell's 2020 pay jumps 21% to $1.7M
March 25, 2021
Eleven Biotherapeutics CEO Thomas Cannell's 2019 pay falls 30% to $1.4M
March 30, 2020
Eleven Biotherapeutics CEO Thomas Cannell receives $2M in 2018
April 30, 2019